TARA
#3535
Protara Therapeutics, Inc. - Common Stock
4.1 2 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.73%
Monthly Change
+7.57%
6 month change
-15.75%
Year Change
+29.97%
Previous Close
4.0 9
Open
4.1 2
Low
4.1 2
High
4.1 2
Volume
27
Financials
- Market Capitalization 231.56 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.83
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3516 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.56 USD | -0.84% | -4.56% | +2.01% | -54.71% | 237.21 M USD | ||
| 3534 |  AVXL Anavex Life Sciences Corp. - Common Stock | 2.50 USD | +2.88% | -7.75% | -3.85% | -77.68% | 231.68 M USD | ||
| 3553 |  DTIL Precision BioSciences, Inc. - Common Stock | 8.81 USD | +2.68% | -3.40% | +39.84% | +97.98% | 227.32 M USD | ||
| 3562 |  CGEN Compugen Ltd. - Ordinary Shares | 2.36 USD | +2.61% | -4.45% | +16.26% | +56.29% | 223.15 M USD |
Frequently asked questions about Protara Therapeutics, Inc. - Common Stock
What is the Protara Therapeutics, Inc. - Common Stock stock price today?
The current price of Protara Therapeutics, Inc. - Common Stock (TARA) is 4.12. Over the past 24 hours, the stock has changed by +0.73%. Follow the TARA chart for real-time price dynamics.
What is the stock ticker of Protara Therapeutics, Inc. - Common Stock?
Protara Therapeutics, Inc. - Common Stock trades under the ticker TARA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Protara Therapeutics, Inc. - Common Stock stock going up?
TARA has changed by 0.00% over the last week, +7.57% over the last month, and +29.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Protara Therapeutics, Inc. - Common Stock net income for the last quarter?
Protara Therapeutics, Inc. - Common Stock reported net income of -17.78 M for the last quarter. The previous quarter showed -17.31 M, which means net income changed by -2.74%.
How many employees does Protara Therapeutics, Inc. - Common Stock have?
As of the latest available data, Protara Therapeutics, Inc. - Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
What is Protara Therapeutics, Inc. - Common Stock EBITDA?
Protara Therapeutics, Inc. - Common Stock EBITDA is -19.53 M, and its EBITDA margin is -244.14 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Protara Therapeutics, Inc. - Common Stock stock?
You can buy Protara Therapeutics, Inc. - Common Stock (TARA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Protara Therapeutics, Inc. - Common Stock stock?
Investing in Protara Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARA chart and related analysis on metatrader.com as part of your research.